Compare BBNX & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBNX | KOP |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 536.4M |
| IPO Year | N/A | 2005 |
| Metric | BBNX | KOP |
|---|---|---|
| Price | $10.37 | $37.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $26.22 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 1.1M | 207.5K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | N/A | ★ 11.38 |
| EPS | N/A | ★ 2.74 |
| Revenue | N/A | ★ $1,879,300,000.00 |
| Revenue This Year | $34.99 | $4.24 |
| Revenue Next Year | $34.47 | $0.97 |
| P/E Ratio | ★ N/A | $13.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.89 | $23.54 |
| 52 Week High | $32.71 | $39.27 |
| Indicator | BBNX | KOP |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 62.62 |
| Support Level | N/A | $26.62 |
| Resistance Level | $15.53 | $39.27 |
| Average True Range (ATR) | 0.67 | 1.67 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 11.22 | 68.27 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.